Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changhoon Yoo

Showing results (121-130 of 250) with videos related to

Pageof 25
Sort By:
Cancer Research and Treatment|December 23, 2017
Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer OnlySu-Jin Shin, Hosub Park, You-Na Sung, et al.
Annals of Surgical Oncology|June 3, 2026
Benefit of Adjuvant Therapy After Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic Review and Meta-analysisMichael C Frey, Victor Lopez-Lopez, Alessia Benz, et al.
Investigational New Drugs|April 10, 2014
Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: randomized phase II multicenter trialSung-Bae Kim, Changhoon Yoo, Jungsil Ro, et al.
Cancer Research and Treatment|July 22, 2015
Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast CancerChanghoon Yoo, Sung-Bae Kim, Jungsil Ro, et al.
Cancer Research and Treatment|December 19, 2025
Utilization, Reimbursement, and Barriers to Accessing Sequencing Tests for Cancer Care in the Asia-Pacific Region: KSMO Initiatives to Address Cancer Care InequityOmali Pitiyarachchi, Aaron C Tan, Tawasapon Thambamroong, et al.
Annals of Surgical Oncology|June 15, 2026
ASO Visual Abstract: Benefit of Adjuvant Therapy after Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic Review and Meta-analysisMichael C Frey, Victor Lopez-Lopez, Alessia Benz, et al.
Anticancer Research|January 25, 2023
Epithelial-Mesenchymal Transition Phenotype and Peritumoral Immune Cell Infiltration in Advanced Biliary Tract CancerChung Ryul Oh, Hyung-Don Kim, Yeon-Mi Ryu, et al.
European Journal of Cancer (Oxford, England : 1990)|February 10, 2015
Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancerMin-Hee Ryu, Changhoon Yoo, Jong Gwang Kim, et al.
JAMA Oncology|March 23, 2023
Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract Cancer: The Phase 2b NIFTY Randomized Clinical TrialJaewon Hyung, Ilhwan Kim, Kyu-Pyo Kim, et al.
Abdominal Radiology (New York)|May 27, 2024
Comparison of the different versions of NCCN guidelines for predicting margin-negative resection of pancreatic cancer in patients undergoing upfront surgeryEun Joo Park, Jong Keon Jang, Jae Ho Byun, et al.
Pageof 25

Showing results (121-130 of 250) with videos related to

Sort By:
Pageof 25
Cancer Research and Treatment|December 23, 2017
Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer OnlySu-Jin Shin, Hosub Park, You-Na Sung, et al.
Annals of Surgical Oncology|June 3, 2026
Benefit of Adjuvant Therapy After Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic Review and Meta-analysisMichael C Frey, Victor Lopez-Lopez, Alessia Benz, et al.
Investigational New Drugs|April 10, 2014
Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: randomized phase II multicenter trialSung-Bae Kim, Changhoon Yoo, Jungsil Ro, et al.
Cancer Research and Treatment|July 22, 2015
Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast CancerChanghoon Yoo, Sung-Bae Kim, Jungsil Ro, et al.
Cancer Research and Treatment|December 19, 2025
Utilization, Reimbursement, and Barriers to Accessing Sequencing Tests for Cancer Care in the Asia-Pacific Region: KSMO Initiatives to Address Cancer Care InequityOmali Pitiyarachchi, Aaron C Tan, Tawasapon Thambamroong, et al.
Annals of Surgical Oncology|June 15, 2026
ASO Visual Abstract: Benefit of Adjuvant Therapy after Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic Review and Meta-analysisMichael C Frey, Victor Lopez-Lopez, Alessia Benz, et al.
Anticancer Research|January 25, 2023
Epithelial-Mesenchymal Transition Phenotype and Peritumoral Immune Cell Infiltration in Advanced Biliary Tract CancerChung Ryul Oh, Hyung-Don Kim, Yeon-Mi Ryu, et al.
European Journal of Cancer (Oxford, England : 1990)|February 10, 2015
Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancerMin-Hee Ryu, Changhoon Yoo, Jong Gwang Kim, et al.
JAMA Oncology|March 23, 2023
Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract Cancer: The Phase 2b NIFTY Randomized Clinical TrialJaewon Hyung, Ilhwan Kim, Kyu-Pyo Kim, et al.
Abdominal Radiology (New York)|May 27, 2024
Comparison of the different versions of NCCN guidelines for predicting margin-negative resection of pancreatic cancer in patients undergoing upfront surgeryEun Joo Park, Jong Keon Jang, Jae Ho Byun, et al.
Pageof 25